Clinical Trial Update: Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome

View source ↗

Summary

Clinical trial platform in head and neck carcinoma focusing on molecular and blood-based biomarkers, treatment, and outcomes is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Hypopharynx
• Squamous Cell Carcinoma of the Larynx
• Squamous Cell Carcinoma of the Oral Cavity
• Squamous Cell Carcinoma of the Oropharynx

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Oropharynx | Status: RECRUITING